Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). [electronic resource]
Producer: 20130211Description: 1213-20 p. digitalISSN:- 1549-490X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- analogs & derivatives
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Female
- France -- epidemiology
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Leiomyosarcoma -- drug therapy
- Lenograstim
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Recombinant Proteins -- therapeutic use
- Taxoids -- therapeutic use
- Uterine Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.